The Gut "Connections to Health & Disease"

Coenzyme Q serves as the linking molecule between different metabolic pathways. Indeed, this essential endogenously synthesized molecule is the cornerstone of many energy production pathways. Furthermore, its location in the inner mitochondrial membrane and its antioxidant capacity protect against oxidative stress. Coenzyme Q supplementation improves essential mitochondrial functions protecting against aging-associated diseases.

Coenzyme Q Biosynthesis:

The coenzyme Q molecule has two central parts; the first is a benzoquinone ring, while the second is a long polyisoprenoid lipid chain. Consequently, the chemical characteristics of its composition provide coenzyme Q with different capabilities. For instance, the benzoquinone ring has redox sites that allow coenzyme Q’s antioxidant properties. In addition, its lipid chain provides coenzymes Q’s beneficial location at the mitochondrial inner membrane; therefore, its function in the electron transport chain.

 

Electron Transport Chain

 

Coenzyme Q’s synthesis is not fully elucidated and has many different synthesis pathways being studied at present. Nevertheless, while some researchers suggest that CoQ synthesizes in the mitochondria, others indicate that CoQ has its synthesis driven by the endoplasmic reticulum or depends on extramitochondrial pools of CoQ.

 

• Furthermore, the structural biosynthesis of CoQ divides into four stages: 

1. Quinone synthesis: Dependent on benzoquinone as the primary aromatic precursor, utilizing phenylalanine or tyrosine as ring precursors. In addition, other aromatic ring precursors can incorporate into CoQ’s synthesis in the presence of a genetic mutation. These precursors can be 2,4-dihydroxybenzoic acid (2,4-diHB), 3,4-dihydroxybenzoic acid (3,4-diHB), and vanillic acid.
2. Isoprenoid tail synthesis: The addition of dimethylally pyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP) creates decaprenyl diphosphate and nonaprenyl diphosphate. The precursors of this synthesis come from the mevalonate pathway.
3. Condensation of both molecules (quinone and isoprenoid): The attachment between the ring structure and the isoprenoid tail is catalyzed by CoQ2.
4. Ring modification: Finally, this condensed molecule undergoes ring modification through various reactions of methylations, decarboxylation, and hydroxylations which lead to the generation of CoQ9 or CoQ10.

 

Different enzymes modulate these reactions. Among them, enzymes from the flavin-dependent monooxygenase family come into play and S-adenosyl methionine (SAM)-dependent methyltransferase.

Pathogenic gene mutations affecting CoQ synthesis:

There are several autosomal recessive mutations in CoQ genes that can cause primary ubiquinone deficiency. Furthermore, these mutations can affect patients and show signs and symptoms like fatigue, muscle weakness, learning disabilities, seizures, encephalopathy, epilepsy, dystonia, and cardiomyopathy. 

 

Some of the identified pathogenic gene mutations associated with these mitochondrial disease symptoms are:

 

• PDSS1 and PDSS2
• CoQ2
• CoQ6
• CoQ7
• CoQ4
• CoQ5
• CoQ8A and CoQ8B
• CoQ9

Anti-aging effect of CoQ10 supplementation:

The number of studies on CoQ10 supplementation has risen during the past decade, along with positive anti-aging and longevity results. Indeed, CoQ 10 antioxidant properties increase mitochondrial function by combating ROS production and reduce oxidative damage.

 

The dose and time of CoQ10 supplementation vary within studies, but most of them agree that the positive effects are strongly associated with a long-term supplementation period. This information is related to the observation of CoQ10 lack of accumulation after the ending of the supplementation period. 

Some of the results associated with CoQ 10 supplementation are:

 

• The attenuation of oxidative damage of proteins in the lived of aged mice.
• Reduced oxidative stress on muscle mitochondria due to increased antioxidant enzyme activation and higher levels of ROS scavengers.
• In humans, the supplementation of 1200mg/day in patients undergoing hemodialysis reduced F2-isoprostane concentration. 

Maintaining mitochondrial health and function is paramount to prevent aging-associated diseases. Mitochondrial energy production will inevitably lead to the formation of ROS. Therefore, Coenzyme Q10 supplementation has proven to delay aging reactions, protecting the mitochondria against ROS and preventing cardiometabolic diseases. – Ana Paola Rodríguez Arciniega, MS

References:

 

Díaz-Casado, M Elena et al. “The Paradox of Coenzyme Q10 in Aging.” Nutrients vol. 11,9 2221. 14 Sep. 2019, doi:10.3390/nu11092221

 

Additional Online Links & Resources (Available 24/7)

 

Online Appointments or Consultations: https://bit.ly/Book-Online-Appointment

 

Online Physical Injury / Accident Intake Form: https://bit.ly/Fill-Out-Your-Online-History 

 

Online Functional Medicine Assessment: https://bit.ly/functionmed

 

General Disclaimer *

The information herein is not intended to replace a one-on-one relationship with a qualified health care professional, licensed physician, and is not medical advice. We encourage you to make your own health care decisions based on your research and partnership with a qualified health care professional. Our information scope is limited to chiropractic, musculoskeletal, physical medicines, wellness, sensitive health issues, functional medicine articles, topics, and discussions. We provide and present clinical collaboration with specialists from a wide array of disciplines. Each specialist is governed by their professional scope of practice and their jurisdiction of licensure. We use functional health & wellness protocols to treat and support care for the injuries or disorders of the musculoskeletal system. Our videos, posts, topics, subjects, and insights cover clinical matters, issues, and topics that relate to and support, directly or indirectly, our clinical scope of practice.* Our office has made a reasonable attempt to provide supportive citations and has identified the relevant research study or studies supporting our posts. We provide copies of supporting research studies available to regulatory boards and the public upon request.

We understand that we cover matters that require an additional explanation of how it may assist in a particular care plan or treatment protocol; therefore, to further discuss the subject matter above, please feel free to ask Dr. Alex Jimenez or contact us at 915-850-0900.

 

Dr. Alex Jimenez DC, MSACP, CCST, IFMCP*, CIFM*, ATN*

email: coach@elpasofunctionalmedicine.com

Licensed in: Texas & New Mexico*